Navigation Links
Dr. Farshchian: Muscle Atrophy a Major Problem with Arthritis, is Being Treated with Cell Therapy at the Center for Regenerative Medicine
Date:12/4/2012

(PRWEB) December 04, 2012

Muscle atrophy a major problem with arthritis, could be treated with regenerative medicine, according to Dr. Farshchian from the Center for Regenerative Medicine.

Muscle atrophy also known as Muscle wasting Is common in arthritis and is usually due to loss of muscle tissue which could be caused by disease or lack of use. Mostly it is caused from disuse. Some of the other causes of atrophy are:

•diabetes (diabetic neuropathy)

•burns

•poliomyelitis

•amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease)

•Guillain-Barre syndrome

•muscular dystrophy

•myotonia congenita

•myotonic dystrophy

•some atrophy that occurs normally with aging

•cerebrovascular accident (stroke)

•spinal cord injury

•peripheral nerve injury (peripheral neuropathy)

•prolonged immobilization

•rheumatoid arthritis

•prolonged corticosteroid therapy

The Center for Regenerative Medicine in Miami, Florida concentrates on helping arthritic and injured people to get back to a functional level of life and their activities using non-surgical techniques and Orthopedic medicine. The center's expertise is in treatment of conditions of spine, knees, shoulders and other cartilage damages. They have developed non-surgical and rehabilitation techniques focused on treatment and management of joint pain. Their team includes health professionals organized around a central theme. Their website is http://www.arthritisusa.net

Read the full story at http://www.prweb.com/releases/2012/12/prweb10148006.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
2. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
3. Mayo Clinic study links healthy muscle mass to healthy bones, finds differences by gender
4. Experimental drug improves muscle strength among male cancer patients
5. Muscle Mass Linked to Bone Health in Some Parts of Body
6. Heuer M.D. Research Announces CardiaShred™ - First Medical Doctor Formulated, Heart Healthy Weight Loss, Energy and Lean Muscle Building Supplement
7. Strong communication between brain and muscle requires both having the protein LRP4
8. Lab-engineered muscle implants restore function in animals
9. Stroke disrupts how brain controls muscle synergies
10. New technique helps determine degree of muscle wasting in critically ill patients
11. Tension on gut muscles induces cell invasion in zebrafish intestine, mimicking cancer metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... The Texas Cord ... recently to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg ... give birth at the hospital and decide to donate. , “Women’s Hospital at ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... 2017 , ... Researchers at Moffitt Cancer Center ... Data Hub in a sample of participants enrolled in an ongoing cancer quality-of-life ... solutions for the global scientific community. The company’s new CentrePoint Data Hub is ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the publication ... a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. ... long-term care, Brooke Grove now has the capability to achieve its goal for ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
Breaking Medicine Technology: